Induced pluripotent stem cells from GMP-grade hematopoietic progenitor cells and mononuclear myeloid cells

INTRODUCTION: The induced pluripotent stem cell (iPSC) technology allows generation of patient-specific pluripotent stem cells, thereby providing a novel cell-therapy platform for severe degenerative diseases. One of the key issues for clinical-grade iPSC derivation is the accessibility of donor cel...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Ohmine, Seiga, Dietz, Allan B, Deeds, Michael C, Hartjes, Katherine A, Miller, David R, Thatava, Tayaramma, Sakuma, Toshie, Kudva, Yogish C, Ikeda, Yasuhiro
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2011
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3340555/
https://ncbi.nlm.nih.gov/pubmed/22088171
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/scrt87
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados